COIOSDeep risk insights through multi-disciplinary research across the globe
gray concrete building near green trees during daytime
Item refines Peer-reviewed Added

Solid second cancers after Hodgkin lymphoma in women fell as radiotherapy declined

In 7,428 women with Hodgkin lymphoma, solid second cancer risk fell 25% across eras, largely explained by reduced radiotherapy.

This population-based cohort followed 7,428 women diagnosed with Hodgkin lymphoma before age 36 in England and Wales, 1954 to 2010. Over a median 20.2 years, 1,200 women developed 1,467 invasive cancers (standardised incidence ratio 3.3), mostly breast, lung and thyroid. Solid cancer risk rose with radiotherapy dose and fell by 25% between 1954-1989 and 2000-2010. Adjusting for radiotherapy made this fall small and non-significant, whereas adjusting for chemotherapy did not change it. Blood cancer risks did not fall, and cumulative incidence of second cancers reached 36% at 50 years. The cohort excludes women diagnosed at 36 or older and anyone treated after 2010.

Why it is interesting: It links a fall in second solid cancers after Hodgkin lymphoma to changes in radiotherapy across six decades. Excess breast and lung cancer risk persisted beyond 50 years of follow-up.

Source
Journal of Clinical Oncology, 12 November 2026
Paper
Second Cancer Risk in Female Survivors of Hodgkin Lymphoma: A National Cohort Analysis Across Treatment Eras
Authors
Macklin-Doherty A, Cunningham D, Chau I, Bates A, Benstead K, Bower M et al.
DOI
10.1200/jco-26-00418
Type
Peer-reviewed article
Design
Population-based cohort, 7,428 women diagnosed with Hodgkin lymphoma before age 36 in England and Wales 1954-2010, cancer registry linkage to 2018, median follow-up 20.2 years
Verdict
Refines prior evidence
Driver
Cancer

Other drivers in Health today